These results suggest that the increase in oxidative stress in diabetes in vivo and hyperglycemia in vitro causes a decrease in miR-133a expression leading to an increase in RhoA/Rho kinase pathway and muscle contraction. The gene discussed is RHOA; the disease is diabetes mellitus.